early period senile cataract
Conditions
Interventions
experimental group: benzalalysine eye drops
control group:placebo
Sponsors
Zhongshan Ophthalmic Center of Sun Yat-Sen University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Subjects who meet all of the following criteria may be enrolled in this trial: (1) 50-70 years old, willing to participate in the test, able to follow up on time; (2) ETDRS visual acuity chart test: corrected vision 0.3-0.7; (3) When the pupil reaches 8 mm after mydriasis, the lens cortex is turbid by slit-lamp microscopy, which is the initial stage; (4) Patients with bilateral cataract; (5) Exclude other eye diseases affecting corrected vision, such as corneal diseases, glaucoma, fundus diseases, etc; (6) No history of systemic or local treatment of cataract; (7) Voluntary participant and signer of informed consent.
Exclusion criteria
Exclusion criteria: If the subject meets any of the following criteria, the conditions for entering the test are not met: (1) Abnormal liver and kidney function; (2) Patients with serious cardiovascular and cerebrovascular diseases, malignant tumors and other diseases; (3) Patients with diabetic retinopathy and other fundus diseases; (4) With a history of mental illness; (5) Those who cannot be followed up on time; (6) Pregnancy, lactation or expectant pregnancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| turbidity of crystalline lens under slit-lamp;BCVA;OQAS; | — |
Countries
China
Contacts
Public ContactJian Ge
Zhongshan Ophthalmic Center, Sun Yat-Sen University
Outcome results
None listed